Recruiting NA INTERVENTIONAL 2-arm NCT05280353

Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain (GALA)

Seroma Control in Axillary Lymphadenectomy With Glubran 2® Without Drain. Multicenter, Prospective, Randomized Clinical Trial. GALA-ND Study (Glu Axillary Lymphadenectomy Ambulatory- no Drain)

Sponsor: Consorci Sanitari del Maresme

Conditions Seroma Following Procedure

Interventions Glubran 2

Updated 6 times since 2022 Last updated: Sep 2, 2024 Started: Apr 1, 2022 Primary completion: Jun 1, 2025 Completion: Jun 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05280353, this NA trial focuses on Seroma Following Procedure and remains actively recruiting participants. Sponsored by Consorci Sanitari del Maresme, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Oct 2024 — Present [monthly]

Recruiting NA
Sep 2024 — Oct 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2024 — Jul 2024 [monthly]

Recruiting NA
Dec 2022 — May 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Apr 2022 — Dec 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Consorci Sanitari del Maresme
Omphis Foundation

Data source: Omphis Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mataró, Spain